Animal health company Zoetis (NYSE: ZTS) and pharmaceutical giant Eli Lilly (NYSE: LLY) are healthcare companies that are off to solid starts this year, with Zoetis' shares up more than 30% and Lilly seeing a 23% rise to start the year. Despite their relatively high valuations, I think both companies make solid long-term choices for increasing wealth, thanks to market tailwinds for both.

Zoetis has been around for 70 years. The company's products cover everything connected to livestock and companion animals, including diagnostics, vaccines, and medicines. The company has more than 300 product lines, including 15 with revenue of $100 million or more last year.

I like the company's long-term prospects because a growing worldwide population is creating a greater need for animal protein, making Zoetis' products more important, and our increasing willingness to spend on pets will drive demand as well.

Continue reading

Source Fool.com